A new study in China is examining how a new methadone substitute may reduce HIV transmission risk among injection-drug users, thePhiladelphia Inquirerreports (philly.com, 5/26). David Metzger, a researcher from the AIDS Prevention Research Division at the University of Pennsylvania, is leading the trial, which is funded by the National Institutes of Health.
According to the article, the drug Metzger is testing—Suboxone—is more expensive than methadone but has an easier withdrawal. It is therefore safer to prescribe to those recovering from heroin addiction. The trial will take place in the Xinjiang capital of Urumqi, where over 30 percent of injection-drug users are already HIV positive.
“We have a moral obligation to be in places where drug use is driving the AIDS epidemic, and Western China is one of those areas,” Metzger told the Inquirer. He later added, “If we can show that the use of this medicine during a one-year treatment program reduces risk behaviors and has a sustained effect on reducing HIV infection, that is our goal.”
NEW! Scroll down to comment on this story.
Please click OK to confirm your comment and confirm you accept our posting rules. Note your message will be reviewed by our staff before going live.
"I am psychologically suffering from body wasting, mainly hips, face, legs and arms. Does anyone know where I can order something (maybe underwear with foam) to fill the sunken hips, so that pants can start looking normal? I feel pathetic when I look at myself in the mirror in jeans—jeans used to fill up so nicely, now they just hang!"
